GR74922B - - Google Patents

Info

Publication number
GR74922B
GR74922B GR64893A GR810164893A GR74922B GR 74922 B GR74922 B GR 74922B GR 64893 A GR64893 A GR 64893A GR 810164893 A GR810164893 A GR 810164893A GR 74922 B GR74922 B GR 74922B
Authority
GR
Greece
Application number
GR64893A
Inventor
Terence James Ward
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of GR74922B publication Critical patent/GR74922B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR64893A 1980-05-27 1981-05-08 GR74922B (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8017377 1980-05-27
GB8104410 1981-02-12

Publications (1)

Publication Number Publication Date
GR74922B true GR74922B (el) 1984-07-12

Family

ID=26275656

Family Applications (1)

Application Number Title Priority Date Filing Date
GR64893A GR74922B (el) 1980-05-27 1981-05-08

Country Status (18)

Country Link
US (1) US4443467A (el)
EP (1) EP0040947B1 (el)
AU (1) AU539121B2 (el)
CA (1) CA1158558A (el)
DE (1) DE3175672D1 (el)
DK (1) DK228381A (el)
ES (3) ES502487A0 (el)
FI (1) FI811601L (el)
GB (1) GB2080107B (el)
GR (1) GR74922B (el)
IL (1) IL62809A (el)
IT (1) IT1136619B (el)
MX (1) MX6962E (el)
MY (1) MY8700598A (el)
NZ (1) NZ197026A (el)
PH (2) PH16855A (el)
PT (1) PT73087B (el)
ZW (1) ZW11381A1 (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4714707A (en) * 1984-01-13 1987-12-22 Rorer Pharmaceutical Corporation Aryl substituted heterocycles for treating gastrointestinal motility dysfunction
GB8525013D0 (en) * 1985-10-10 1985-11-13 Wyeth John & Brother Ltd Antidiarrhoel agents
DK153442C (da) * 1985-10-14 1988-12-19 Poul Bachmann Middel, baseret paa pektinholdigt materiale, til behandling og forebyggelse af diarre hos mennesker og dyr
GB8806224D0 (en) * 1988-03-16 1988-04-13 Johnson Matthey Plc Platinum chemotherapeutic product
US20050191403A1 (en) * 2002-05-23 2005-09-01 Glutagen Pty Ltd Palliative treatment for gluten intolerance
US7976872B2 (en) * 2006-07-24 2011-07-12 L. Perrigo Company Method for distributing a pharmaceutically active compound in an excipient

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1530675A (en) * 1976-06-05 1978-11-01 Wyeth John & Brother Ltd Guanidine derivatives

Also Published As

Publication number Publication date
AU7020381A (en) 1981-12-03
ES8302647A1 (es) 1983-02-01
MX6962E (es) 1987-01-08
ES502487A0 (es) 1983-02-01
FI811601A7 (fi) 1981-11-28
IT1136619B (it) 1986-09-03
GB2080107A (en) 1982-02-03
ZW11381A1 (en) 1982-11-17
NZ197026A (en) 1984-05-31
IL62809A0 (en) 1981-07-31
ES8305317A1 (es) 1983-04-16
AU539121B2 (en) 1984-09-13
IT8121847A0 (it) 1981-05-20
IL62809A (en) 1984-03-30
EP0040947B1 (en) 1986-12-03
DK228381A (da) 1981-11-28
FI811601L (fi) 1981-11-28
MY8700598A (en) 1987-12-31
PH17361A (en) 1984-08-01
US4443467A (en) 1984-04-17
PH16855A (en) 1984-03-19
ES514336A0 (es) 1983-04-16
DE3175672D1 (en) 1987-01-15
EP0040947A1 (en) 1981-12-02
ES8305316A1 (es) 1983-04-16
PT73087A (en) 1981-06-01
PT73087B (en) 1985-01-08
ES514335A0 (es) 1983-04-16
GB2080107B (en) 1986-02-26
CA1158558A (en) 1983-12-13

Similar Documents

Publication Publication Date Title
FR2483148B1 (el)
FR2490248B3 (el)
FR2478918B1 (el)
FR2473396B1 (el)
FR2476551B1 (el)
FR2475899B1 (el)
FR2490630B1 (el)
FR2475781B1 (el)
FR2490210B1 (el)
FR2488163B1 (el)
FR2486047B1 (el)
FR2477291B1 (el)
GR74670B (el)
FR2478370B1 (el)
FR2492020B1 (el)
FR2484808B3 (el)
FR2487635B1 (el)
FR2488203B2 (el)
FR2479472B1 (el)
FR2492421B1 (el)
FR2485674B1 (el)
FR2491012B1 (el)
FR2490840B3 (el)
FR2489757B1 (el)
FR2483212B1 (el)